NovaBay Pharmaceuticals Inc (NBY)
0.0757
0.00 (0.00%)
USD |
NYAM |
Apr 25, 10:03
NovaBay Pharmaceuticals Cash from Operations (Quarterly): -0.314M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.314M |
| September 30, 2023 | -0.363M |
| June 30, 2023 | -1.843M |
| March 31, 2023 | -1.611M |
| December 31, 2022 | -1.209M |
| September 30, 2022 | -1.689M |
| June 30, 2022 | -1.699M |
| March 31, 2022 | -2.057M |
| December 31, 2021 | -4.318M |
| September 30, 2021 | -1.468M |
| June 30, 2021 | -1.987M |
| March 31, 2021 | -1.419M |
| December 31, 2020 | -1.445M |
| September 30, 2020 | -1.37M |
| June 30, 2020 | -1.041M |
| March 31, 2020 | -0.865M |
| December 31, 2019 | -1.429M |
| September 30, 2019 | -1.50M |
| June 30, 2019 | -1.779M |
| March 31, 2019 | -3.221M |
| December 31, 2018 | -1.993M |
| September 30, 2018 | -1.618M |
| June 30, 2018 | -1.493M |
| March 31, 2018 | -0.464M |
| December 31, 2017 | -2.926M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.281M |
| June 30, 2017 | -1.619M |
| March 31, 2017 | -2.006M |
| December 31, 2016 | -0.22M |
| September 30, 2016 | -3.849M |
| June 30, 2016 | -2.659M |
| March 31, 2016 | -4.933M |
| December 31, 2015 | -4.489M |
| September 30, 2015 | -4.138M |
| June 30, 2015 | -5.425M |
| March 31, 2015 | -4.507M |
| December 31, 2014 | -4.14M |
| September 30, 2014 | -2.746M |
| June 30, 2014 | -3.753M |
| March 31, 2014 | -4.416M |
| December 31, 2013 | -4.675M |
| September 30, 2013 | -2.406M |
| June 30, 2013 | -2.196M |
| March 31, 2013 | -3.692M |
| December 31, 2012 | -3.096M |
| September 30, 2012 | 0.258M |
| June 30, 2012 | -0.954M |
| March 31, 2012 | -2.736M |
| December 31, 2011 | -0.589M |
| September 30, 2011 | 0.781M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.318M
Minimum
Dec 2021
-0.314M
Maximum
Dec 2023
-1.548M
Average
-1.468M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Eyenovia Inc | -6.322M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.002M |
| Cash from Financing (Quarterly) | -0.026M |
| Free Cash Flow | -4.15M |
| Free Cash Flow Per Share (Quarterly) | -0.0281 |
| Free Cash Flow to Equity (Quarterly) | -0.183M |
| Free Cash Flow Yield | -1.04K% |